Low market cap to...it should go hard on publication of positive results. Been a long hard slog this one but it starting to feel like a winner. Not to mention all the families who will benefit from the treatment. As they gather more data through regular use of the product the data itself will become an incredibly valuable asset. Autism is just the tip of the iceberg for these guys methinks.
